MC

502.3

-0.2%↓

SANES

6.953

+0.68%↑

BNP

76.21

-3.93%↓

BBVA

13.48

+0.75%↑

INGA

19.022

+0.49%↑

MC

502.3

-0.2%↓

SANES

6.953

+0.68%↑

BNP

76.21

-3.93%↓

BBVA

13.48

+0.75%↑

INGA

19.022

+0.49%↑

MC

502.3

-0.2%↓

SANES

6.953

+0.68%↑

BNP

76.21

-3.93%↓

BBVA

13.48

+0.75%↑

INGA

19.022

+0.49%↑

MC

502.3

-0.2%↓

SANES

6.953

+0.68%↑

BNP

76.21

-3.93%↓

BBVA

13.48

+0.75%↑

INGA

19.022

+0.49%↑

MC

502.3

-0.2%↓

SANES

6.953

+0.68%↑

BNP

76.21

-3.93%↓

BBVA

13.48

+0.75%↑

INGA

19.022

+0.49%↑

Search

AB Science SA

Atidarymo kaina

1.528 8.99

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

1.402

Max

1.566

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-4.5M

Pardavimai

560K

Pelno marža

-798.036

Darbuotojai

40

EBITDA

-4.6M

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

94M

Ankstesnė atidarymo kaina

-7.46

Ankstesnė uždarymo kaina

1.528

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bearish Evidence

AB Science SA Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-05-18 23:47; UTC

Rinkos pokalbiai

Nikkei May Trade Rangebound Amid Uncertainty Over U.S. Tariffs -- Market Talk

2025-05-18 23:40; UTC

Rinkos pokalbiai

Gold Rises Amid Concerns Over U.S. Fiscal Deficit -- Market Talk

2025-05-18 18:00; UTC

Uždarbis

Tax Bill News; Target, Home Depot, and Snowflake Earnings; and More Stock Market News to Watch This Week -- Barrons.com

2025-05-18 17:01; UTC

Svarbiausios naujienos

GM Is Fighting California on EVs. This Is What It Wants to Overturn and Why. -- Barrons.com

2025-05-18 16:20; UTC

Uždarbis

Tesla Demand Hasn't Rebounded Yet. Watch China This Week. -- Barrons.com

2025-05-18 12:09; UTC

Svarbiausios naujienos

Trump Sounds Upbeat on Ukraine Cease-Fire as Russia Unleashes Drone Barrage -- WSJ

2025-05-17 17:15; UTC

Svarbiausios naujienos

Trump Attacks Walmart for Tariff-Related Price Increases -- WSJ

2025-05-17 09:30; UTC

Svarbiausios naujienos
Uždarbis

In a Trade War, Walmart Lacks Some of Amazon's Ammunition -- Heard on the Street -- WSJ

2025-05-17 08:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-05-17 08:20; UTC

Rinkos pokalbiai
Uždarbis

Financial Services Roundup: Market Talk

2025-05-16 23:18; UTC

Svarbiausios naujienos

U.S. Loses Last Triple-A Credit Rating -- 2nd Update

2025-05-16 22:30; UTC

Svarbiausios naujienos

U.S. Loses Last Triple-A Credit Rating -- Update

2025-05-16 21:56; UTC

Rinkos pokalbiai

Fitch Raises Greece's Outlook to Positive From Stable -- Market Talk

2025-05-16 21:56; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-05-16 21:54; UTC

Svarbiausios naujienos

U.S. Loses Last Triple-A Credit Rating -- WSJ

2025-05-16 21:22; UTC

Rinkos pokalbiai

Moody's Says U.S. Fiscal Performance Likely to Deteriorate -- Market Talk

2025-05-16 21:17; UTC

Rinkos pokalbiai

Treasury Yields Rise, Dollar Falls After Moody's Cuts U.S. Credit Rating -- Market Talk

2025-05-16 21:17; UTC

Svarbiausios naujienos

The Score: UnitedHealth, Walmart, Coinbase Global and More Stocks That Moved on the Week's News -- WSJ

2025-05-16 21:05; UTC

Rinkos pokalbiai

Moody's Downgrades U.S. Credit Rating Due to Deficit, Debts -- Market Talk

2025-05-16 20:55; UTC

Įsigijimai, susijungimai, perėmimai

What's Next for Cable Giant Comcast After Charter-Cox Merger -- Barrons.com

2025-05-16 20:50; UTC

Rinkos pokalbiai
Uždarbis

Financial Services Roundup: Market Talk

2025-05-16 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-05-16 20:37; UTC

Svarbiausios naujienos

Trade Progress Sparks Bullish Week for Wall Street -- WSJ

2025-05-16 20:33; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Dick's-Foot Locker Deal Looks Like a Bet on Nike's Turnaround -- Market Talk

2025-05-16 20:30; UTC

Įsigijimai, susijungimai, perėmimai

Galaxy Digital Begins U.S. Trading as Bitcoin Keeps Powering Ahead -- Barrons.com

2025-05-16 20:18; UTC

Svarbiausios naujienos

Major U.S. Stock Indexes Rise; U.S. Running Out of Patience for Trade Deals -- WSJ

2025-05-16 20:16; UTC

Svarbiausios naujienos

Justice Department Wants to Spare Boeing From Guilty Plea Over 737 MAX Charges -- 3rd Update

2025-05-16 20:15; UTC

Uždarbis

Tesla Stock Rises. Even Hedge Fund Sales Can't Keep It Down. -- Barrons.com

2025-05-16 20:11; UTC

Įsigijimai, susijungimai, perėmimai

Henry Schein: William K. Daniel Joins Board

2025-05-16 20:10; UTC

Įsigijimai, susijungimai, perėmimai

Henry Schein: Strategic Investment by KKR Completed

Akcijų palyginimas

Kainos pokytis

AB Science SA Prognozė

Techninis įvertinimas

By Trading Central

1.426 / 1.448Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Bearish Evidence

Vidutinės trukmės periodas

Bullish Evidence

Ilgalaikis periodas

Bullish Evidence

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę AB Science SA

AB Science S.A., a clinical-stage company, designs and develops novel drugs to various diseases with high unmet medical needs for inflammatory diseases, pathologies affecting peripheral and central nervous system, and cancers in France. The company's lead compound is the masitinib, a tyrosine kinase inhibitor which is in Phase III clinical trials for the treatment of amyotrophic lateral sclerosis, indolent systemic mastocytosis, severe asthma, progressive forms of multiple sclerosis, first line pancreatic cancer with pain, alzheimer's disease, and metastatic castrate-resistant prostate cancer, as well as in Phase II clinical trial to treat Covid-19. It also developing AB8939, a microtubule destabiliser for acute myeloid leukemia. The company markets its masitinib under the Masivet brand in Europe. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France.